Literature DB >> 2993621

Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.

A P IJzerman, G H Aué, T Bultsma, M R Linschoten, H Timmerman.   

Abstract

The influence of the aromatic moiety of beta-adrenoceptor ligands on the affinity for the beta 2-adrenoceptor has been studied. Three classes of ligands have been examined, viz. N-isopropyl- and N-tert-butylphenylethanolamines and N-isopropylphenoxypropanolamines. Computer-assisted analysis of the inhibition by any of these ligands of the specific (-)-[3H]dihydroalprenolol binding to the beta 2-adrenoceptors of a bovine skeletal muscle preparation in the presence of GppNHp (10(-4) M) yielded the affinities of these ligands at pH 7.5. The obtained values were adjusted for the amounts of cations present at this pH value. A significant correlation was found between the calculated lipophilicities and the experimentally determined affinities in the three classes. Furthermore, steric factors seem to play an important role, as these correlations were improved by the introduction of steric parameters for the aromatic substituents in the regression analyses. From the established equations it is concluded that the phenoxypropanolamine derivatives bind to the beta 2-adrenoceptor in a way different from that of the ligands in both ethanolamine classes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993621     DOI: 10.1021/jm00147a037

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Molecular modeling of a putative antagonist binding site on helix III of the beta-adrenoceptor.

Authors:  H W van Vlijmen; A P IJzerman
Journal:  J Comput Aided Mol Des       Date:  1989-06       Impact factor: 3.686

2.  A molecular graphics study exploring a putative ligand binding site of the beta-adrenoceptor.

Authors:  A P IJzerman; H W van Vlijmen
Journal:  J Comput Aided Mol Des       Date:  1988-04       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.